Snehaa Organics Ltd
Incorporated in October 2017, Snehaa Organics Limited operates in solvent recovery, providing sustainable solutions for industries that use solvents.[1]
- Market Cap ₹ 88.7 Cr.
- Current Price ₹ 87.2
- High / Low ₹ 122 / 77.0
- Stock P/E 12.1
- Book Value ₹ 48.0
- Dividend Yield 0.00 %
- ROCE 58.8 %
- ROE 66.1 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 66.9%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 21.73 | 13.65 | 23.72 | 26.22 | |
| 17.24 | 9.48 | 17.90 | 14.73 | |
| Operating Profit | 4.49 | 4.17 | 5.82 | 11.49 |
| OPM % | 20.66% | 30.55% | 24.54% | 43.82% |
| -0.51 | 0.07 | 0.09 | 0.07 | |
| Interest | 0.36 | 0.00 | 0.09 | 0.53 |
| Depreciation | 0.76 | 0.44 | 0.80 | 1.21 |
| Profit before tax | 2.86 | 3.80 | 5.02 | 9.82 |
| Tax % | 46.50% | 26.84% | 27.09% | 25.15% |
| 1.54 | 2.78 | 3.66 | 7.34 | |
| EPS in Rs | 27.80 | 36.60 | 9.79 | |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 6% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 58% |
| TTM: | 101% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 67% |
| Last Year: | 66% |
Balance Sheet
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 4.00 | 1.00 | 1.00 | 7.50 | 10.18 |
| Reserves | 0.00 | 2.78 | 6.44 | 7.28 | 38.67 |
| 3.65 | 3.59 | 3.92 | 9.08 | 5.52 | |
| 2.54 | 3.43 | 5.74 | 6.19 | 6.70 | |
| Total Liabilities | 10.19 | 10.80 | 17.10 | 30.05 | 61.07 |
| 4.49 | 4.58 | 8.10 | 13.98 | 14.80 | |
| CWIP | 0.00 | 0.04 | 0.47 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 5.70 | 6.18 | 8.53 | 16.07 | 46.27 | |
| Total Assets | 10.19 | 10.80 | 17.10 | 30.05 | 61.07 |
Cash Flows
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 1.81 | 1.25 | 4.56 | 3.02 | |
| -1.13 | -0.91 | -4.77 | -7.63 | |
| -1.58 | -0.35 | 0.24 | 4.63 | |
| Net Cash Flow | -0.90 | -0.01 | 0.03 | 0.02 |
Ratios
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 60.64 | 101.34 | 99.87 | 131.27 |
| Inventory Days | 303.14 | 12.04 | 146.72 | |
| Days Payable | 575.34 | 117.03 | 109.94 | |
| Cash Conversion Cycle | 60.64 | -170.86 | -5.12 | 168.05 |
| Working Capital Days | -9.74 | 67.65 | 26.47 | 80.04 |
| ROCE % | 50.60% | 54.56% | 58.77% |
Documents
Announcements
-
Utilisation of Funds
13 November 2025 - IPO Rs32.68 crore; as of 30 Sep 2025, Rs24.74 crore unutilized; no material deviations.
-
Statement of deviation(s) or variation(s) under Reg. 32
13 November 2025 - IPO Rs.32.68 crore; as of 30 Sep 2025 Rs.7.94 crore utilized, Rs.24.74 crore unutilized.
-
Related Party Transactions
13 November 2025 - Disclosure of related-party transactions as on Sep 30, 2025, detailing sales, purchases and remunerations.
-
Outcome of Board Meeting
13 November 2025 - Board approved unaudited half-year results to Sep 30, 2025; IPO proceeds Rs.3,268.38 lakhs; limited review, RPT disclosures.
-
Outcome of Board Meeting
13 November 2025 - Board approved unaudited half-year results to Sept 30, 2025; IPO proceeds Rs32.68 crore; listed on NSE Emerge Sept 5, 2025.
Business Profile[1]
The company operates in solvent recovery and recycling, primarily serving the pharmaceutical industry. Its core activities include job work distillation of spent solvents for customers, direct sales of distilled solvents in the open market, and trading of solvents sourced from suppliers.